MyAverix Finance
NS · Pharmaceuticals
Krebs Biochemicals & Industries Ltd (KREBSBIO)
Pharmaceuticals & Biotechnology
Krebs Biochemicals & Industries Ltd (KREBSBIO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.41B, P/E ratio is -8.46, net margin is -55.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KREBSBIO
Krebs Biochemicals & Industries Ltd (KREBSBIO) — FAQ
What is Krebs Biochemicals & Industries Ltd's market cap?
Krebs Biochemicals & Industries Ltd (KREBSBIO) has a reported market cap of $1.41B (data as of 2026-07-10).
What is KREBSBIO's P/E ratio?
The price-to-earnings (P/E) ratio for Krebs Biochemicals & Industries Ltd (KREBSBIO) is -8.46 (data as of 2026-07-10).
Does Krebs Biochemicals & Industries Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Krebs Biochemicals & Industries Ltd (KREBSBIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Krebs Biochemicals & Industries Ltd in?
Krebs Biochemicals & Industries Ltd (KREBSBIO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is KREBSBIO listed on?
KREBSBIO is listed on NS.
What is Krebs Biochemicals & Industries Ltd's net margin?
Krebs Biochemicals & Industries Ltd (KREBSBIO) reports a net margin of -55.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.